猴头菌
疾病
临床试验
神经保护
安慰剂
医学
药理学
病理
替代医学
作者
M. Muhanna,I. Lund,Mark B. Bromberg,Paul Wicks,Michael Benatar,Benjamin Barnes,Kaitlyn Pierce,Dylan Ratner,Andrew Brown,Tulio E. Bertorini,Paul E. Barkhaus,Gregory Carter,Javier Mascías Cadavid,Christopher McDermott,Jonathan D. Glass,Gary L. Pattee,Carmel Armon,Richard Bedlack,Xiaoyan Li
标识
DOI:10.1080/21678421.2023.2296557
摘要
Lion's Mane (Hericium erinaceus) has historically been used as traditional medicine in Asia and Europe for its potential benefits in fighting infection and cancer. It has gained interest in the neurodegenerative disease field because of its mechanisms of action; these include anti-inflammation, neuroprotection, and promoting neurite growth demonstrated in various cell and animal models. A very small, double-blind, placebo-controlled trial in patients with mild cognitive impairment showed a temporary improvement in cognitive function; this finding has yet to be replicated. However, there have been no studies in ALS cell or animal models or in humans with ALS. Lion's Mane appears safe and inexpensive when consumed in powder or capsule, but one anaphylactic case was reported after a patient consumed fresh Lion's Mane mushroom. Currently, we do not have enough information to support the use of Lion's Mane for treating ALS. We support further research in ALS disease models and clinical trials to study its efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI